Skip to main content

What Will Happen to Japanese Life Sciences Companies Under the Four-Year Biden Administration

Global law firm Greenberg Traurig, LLP Health Care & FDA Practice Shareholder Chia-Feng Lu hosted a webinar with Shonan Health Innovation Park (Shonan i-Park) on March 3. Shonan i-park is an organization and ecosystem comprising researchers, industry experts, venture startups, government, and academia who collaborate and co-create to accelerate research, with the aim of transforming cutting-edge science into impactful health solutions for patients worldwide.

Lu’s webinar helped guide Japanese life sciences companies on what to expect under the four-year Biden administration and discussed managing the new deal making and business operation environment. He outlined the coming changes in terms of product development approach, corporate finance, business development and licensing, and commercialization and operation. Other webinar topics included the Biden Administration’s top health care priorities within the first 100 days in office, how the health care market will be shaped within the next four years, and the potential coverage expansion and drug pricing reform.